News | January 08, 2026
Lilly to buy Ventyx Biosciences for $1.2 billion
Ventyx's clinical pipeline includes multiple small molecules with potential for oral therapies addressing chronic inflammation
Ventyx's clinical pipeline includes multiple small molecules with potential for oral therapies addressing chronic inflammation
Our scientists found that toxicological data for most PFAS are incomplete or unavailable, leaving significant uncertainty about consumer safety
Before this appointment, he served as the Secretary in the Department of Land Resources, Ministry of Rural Development
Despite some promising subgroup signals, the company indicated it will not pursue further psychiatric trials
Ushio, a leader in advanced optical technologies, brings a strong track record and proprietary Photobonding technology
Shonan iPark was chosen for its globally connected life-science ecosystem, which unites pharmaceutical firms, next-generation medicine developers, AI and digital health innovators, venture capital, and academia
NUFYMCO BLA has been approved by the USFDA
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
The announcement came during the inauguration of the college’s Innovation & Incubation Centre and Health Club
Company acquires People Tree Hospital Yeshwanthpur for Rs. 430 crore
Subscribe To Our Newsletter & Stay Updated
